Pictet Asset Management
KYMR icon

Pictet Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Pictet Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45M Sell
395,540
-73,188
-16% -$6.29M 0.04% 357
2026
Q1 		$38.8M Sell
468,728
-14,471
-3% -$1.15M 0.04% 365
2025
Q4 		$37.8M Buy
483,199
+136,382
+39% +$9.21M 0.04% 379
2025
Q3 		$19.8M Buy
346,817
+341,259
+6,140% +$15.4M 0.02% 520
2025
Q2 		$243K Buy
+5,558
New +$191K ﹤0.01% 1735
2024
Q4 		– Sell
-4,685
Closed -$222K – 2067
2024
Q3 		$222K Buy
+4,685
New +$207K ﹤0.01% 1771

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Pictet Asset Management's KYMR Position: Q2 2026 in Review

Pictet Asset Management reduced its Kymera Therapeutics (KYMR) stake by 16% in Q2 2026, selling an estimated $6.29M and leaving 395,540 shares worth $45M. The position accounts for 0.04% of the portfolio, ranked #357.

Pictet Asset Management first reported a position in KYMR in Q3 2024 and has held it in 6 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Pictet Asset Management held 395,540 shares of Kymera Therapeutics worth $45M as of Q2 2026.
  • Pictet Asset Management sold 73,188 Kymera Therapeutics shares in Q2 2026, an estimated $6.29M.
  • Kymera Therapeutics made up 0.04% of Pictet Asset Management's portfolio in Q2 2026, its #357 holding.
  • Pictet Asset Management first reported a position in Kymera Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.